<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Am J Hum Genet</journal-id>
      <journal-id journal-id-type="iso-abbrev">Am J Hum Genet</journal-id>
      <journal-title-group>
        <journal-title>American Journal of Human Genetics</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0002-9297</issn>
      <issn pub-type="epub">1537-6605</issn>
      <publisher>
        <publisher-name>Elsevier</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">34010604</article-id>
      <article-id pub-id-type="pmc">8206386</article-id>
      <article-id pub-id-type="pii">S0002-9297(21)00151-8</article-id>
      <article-id pub-id-type="doi">10.1016/j.ajhg.2021.04.020</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Bi-allelic variants in <italic>IPO8</italic> cause a connective tissue disorder associated with cardiovascular defects, skeletal abnormalities, and immune dysregulation</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" id="au1">
          <name>
            <surname>Ziegler</surname>
            <given-names>Alban</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="aff2" ref-type="aff">2</xref>
          <xref rid="fn1" ref-type="fn">33</xref>
        </contrib>
        <contrib contrib-type="author" id="au2">
          <name>
            <surname>Duclaux-Loras</surname>
            <given-names>R&#xE9;mi</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
          <xref rid="fn1" ref-type="fn">33</xref>
        </contrib>
        <contrib contrib-type="author" id="au3">
          <name>
            <surname>Revenu</surname>
            <given-names>C&#xE9;line</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">4</xref>
          <xref rid="aff5" ref-type="aff">5</xref>
          <xref rid="fn1" ref-type="fn">33</xref>
        </contrib>
        <contrib contrib-type="author" id="au4">
          <name>
            <surname>Charbit-Henrion</surname>
            <given-names>Fabienne</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
          <xref rid="aff6" ref-type="aff">6</xref>
          <xref rid="aff7" ref-type="aff">7</xref>
        </contrib>
        <contrib contrib-type="author" id="au5">
          <name>
            <surname>Begue</surname>
            <given-names>Bernadette</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author" id="au6">
          <name>
            <surname>Duroure</surname>
            <given-names>Karine</given-names>
          </name>
          <xref rid="aff4" ref-type="aff">4</xref>
          <xref rid="aff5" ref-type="aff">5</xref>
        </contrib>
        <contrib contrib-type="author" id="au7">
          <name>
            <surname>Grimaud</surname>
            <given-names>Linda</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author" id="au8">
          <name>
            <surname>Guihot</surname>
            <given-names>Anne Laure</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author" id="au9">
          <name>
            <surname>Desquiret-Dumas</surname>
            <given-names>Val&#xE9;rie</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author" id="au10">
          <name>
            <surname>Zarhrate</surname>
            <given-names>Mohammed</given-names>
          </name>
          <xref rid="aff8" ref-type="aff">8</xref>
        </contrib>
        <contrib contrib-type="author" id="au11">
          <name>
            <surname>Cagnard</surname>
            <given-names>Nicolas</given-names>
          </name>
          <xref rid="aff9" ref-type="aff">9</xref>
        </contrib>
        <contrib contrib-type="author" id="au12">
          <name>
            <surname>Mas</surname>
            <given-names>Emmanuel</given-names>
          </name>
          <xref rid="aff10" ref-type="aff">10</xref>
          <xref rid="aff11" ref-type="aff">11</xref>
        </contrib>
        <contrib contrib-type="author" id="au13">
          <name>
            <surname>Breton</surname>
            <given-names>Anne</given-names>
          </name>
          <xref rid="aff10" ref-type="aff">10</xref>
          <xref rid="aff11" ref-type="aff">11</xref>
        </contrib>
        <contrib contrib-type="author" id="au14">
          <name>
            <surname>Edouard</surname>
            <given-names>Thomas</given-names>
          </name>
          <xref rid="aff12" ref-type="aff">12</xref>
        </contrib>
        <contrib contrib-type="author" id="au15">
          <name>
            <surname>Billon</surname>
            <given-names>Clarisse</given-names>
          </name>
          <xref rid="aff13" ref-type="aff">13</xref>
        </contrib>
        <contrib contrib-type="author" id="au16">
          <name>
            <surname>Frank</surname>
            <given-names>Michael</given-names>
          </name>
          <xref rid="aff13" ref-type="aff">13</xref>
        </contrib>
        <contrib contrib-type="author" id="au17">
          <name>
            <surname>Colin</surname>
            <given-names>Estelle</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
        </contrib>
        <contrib contrib-type="author" id="au18">
          <name>
            <surname>Lenaers</surname>
            <given-names>Guy</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author" id="au19">
          <name>
            <surname>Henrion</surname>
            <given-names>Daniel</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author" id="au20">
          <name>
            <surname>Lyonnet</surname>
            <given-names>Stanislas</given-names>
          </name>
          <xref rid="aff14" ref-type="aff">14</xref>
          <xref rid="aff15" ref-type="aff">15</xref>
        </contrib>
        <contrib contrib-type="author" id="au21">
          <name>
            <surname>Faivre</surname>
            <given-names>Laurence</given-names>
          </name>
          <xref rid="aff16" ref-type="aff">16</xref>
        </contrib>
        <contrib contrib-type="author" id="au22">
          <name>
            <surname>Alembik</surname>
            <given-names>Yves</given-names>
          </name>
          <xref rid="aff17" ref-type="aff">17</xref>
        </contrib>
        <contrib contrib-type="author" id="au23">
          <name>
            <surname>Philippe</surname>
            <given-names>Ana&#xEF;s</given-names>
          </name>
          <xref rid="aff17" ref-type="aff">17</xref>
        </contrib>
        <contrib contrib-type="author" id="au24">
          <name>
            <surname>Moulin</surname>
            <given-names>Bruno</given-names>
          </name>
          <xref rid="aff18" ref-type="aff">18</xref>
        </contrib>
        <contrib contrib-type="author" id="au25">
          <name>
            <surname>Reinstein</surname>
            <given-names>Eyal</given-names>
          </name>
          <xref rid="aff19" ref-type="aff">19</xref>
          <xref rid="aff20" ref-type="aff">20</xref>
        </contrib>
        <contrib contrib-type="author" id="au26">
          <name>
            <surname>Tzur</surname>
            <given-names>Shay</given-names>
          </name>
          <xref rid="aff21" ref-type="aff">21</xref>
        </contrib>
        <contrib contrib-type="author" id="au27">
          <name>
            <surname>Attali</surname>
            <given-names>Ruben</given-names>
          </name>
          <xref rid="aff21" ref-type="aff">21</xref>
        </contrib>
        <contrib contrib-type="author" id="au28">
          <name>
            <surname>McGillivray</surname>
            <given-names>George</given-names>
          </name>
          <xref rid="aff22" ref-type="aff">22</xref>
        </contrib>
        <contrib contrib-type="author" id="au29">
          <name>
            <surname>White</surname>
            <given-names>Susan M.</given-names>
          </name>
          <xref rid="aff22" ref-type="aff">22</xref>
        </contrib>
        <contrib contrib-type="author" id="au30">
          <name>
            <surname>Gallacher</surname>
            <given-names>Lyndon</given-names>
          </name>
          <xref rid="aff22" ref-type="aff">22</xref>
          <xref rid="aff23" ref-type="aff">23</xref>
        </contrib>
        <contrib contrib-type="author" id="au31">
          <name>
            <surname>Kutsche</surname>
            <given-names>Kerstin</given-names>
          </name>
          <xref rid="aff24" ref-type="aff">24</xref>
        </contrib>
        <contrib contrib-type="author" id="au32">
          <name>
            <surname>Schneeberger</surname>
            <given-names>Pauline</given-names>
          </name>
          <xref rid="aff24" ref-type="aff">24</xref>
        </contrib>
        <contrib contrib-type="author" id="au33">
          <name>
            <surname>Girisha</surname>
            <given-names>Katta M.</given-names>
          </name>
          <xref rid="aff25" ref-type="aff">25</xref>
        </contrib>
        <contrib contrib-type="author" id="au34">
          <name>
            <surname>Nayak</surname>
            <given-names>Shalini S.</given-names>
          </name>
          <xref rid="aff25" ref-type="aff">25</xref>
        </contrib>
        <contrib contrib-type="author" id="au35">
          <name>
            <surname>Pais</surname>
            <given-names>Lynn</given-names>
          </name>
          <xref rid="aff26" ref-type="aff">26</xref>
        </contrib>
        <contrib contrib-type="author" id="au36">
          <name>
            <surname>Maroofian</surname>
            <given-names>Reza</given-names>
          </name>
          <xref rid="aff27" ref-type="aff">27</xref>
        </contrib>
        <contrib contrib-type="author" id="au37">
          <name>
            <surname>Rad</surname>
            <given-names>Aboulfazl</given-names>
          </name>
          <xref rid="aff28" ref-type="aff">28</xref>
        </contrib>
        <contrib contrib-type="author" id="au38">
          <name>
            <surname>Vona</surname>
            <given-names>Barbara</given-names>
          </name>
          <xref rid="aff28" ref-type="aff">28</xref>
          <xref rid="aff29" ref-type="aff">29</xref>
        </contrib>
        <contrib contrib-type="author" id="au39">
          <name>
            <surname>Karimiani</surname>
            <given-names>Ehsan Ghayoor</given-names>
          </name>
          <xref rid="aff30" ref-type="aff">30</xref>
          <xref rid="aff31" ref-type="aff">31</xref>
        </contrib>
        <contrib contrib-type="author" id="au40">
          <name>
            <surname>Lekszas</surname>
            <given-names>Caroline</given-names>
          </name>
          <xref rid="aff29" ref-type="aff">29</xref>
        </contrib>
        <contrib contrib-type="author" id="au41">
          <name>
            <surname>Haaf</surname>
            <given-names>Thomas</given-names>
          </name>
          <xref rid="aff29" ref-type="aff">29</xref>
        </contrib>
        <contrib contrib-type="author" id="au42">
          <name>
            <surname>Martin</surname>
            <given-names>Ludovic</given-names>
          </name>
          <xref rid="aff2" ref-type="aff">2</xref>
          <xref rid="aff32" ref-type="aff">32</xref>
        </contrib>
        <contrib contrib-type="author" id="au43">
          <name>
            <surname>Ruemmele</surname>
            <given-names>Frank</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
          <xref rid="aff6" ref-type="aff">6</xref>
        </contrib>
        <contrib contrib-type="author" id="au44">
          <name>
            <surname>Bonneau</surname>
            <given-names>Dominique</given-names>
          </name>
          <xref rid="aff1" ref-type="aff">1</xref>
          <xref rid="aff2" ref-type="aff">2</xref>
        </contrib>
        <contrib contrib-type="author" id="au45">
          <name>
            <surname>Cerf-Bensussan</surname>
            <given-names>Nadine</given-names>
          </name>
          <xref rid="aff3" ref-type="aff">3</xref>
        </contrib>
        <contrib contrib-type="author" id="au46">
          <name>
            <surname>Del Bene</surname>
            <given-names>Filippo</given-names>
          </name>
          <email>filippo.del-bene@inserm.fr</email>
          <xref rid="aff4" ref-type="aff">4</xref>
          <xref rid="aff5" ref-type="aff">5</xref>
          <xref rid="cor1" ref-type="corresp">&#x2217;</xref>
        </contrib>
        <contrib contrib-type="author" id="au47">
          <name>
            <surname>Parlato</surname>
            <given-names>Marianna</given-names>
          </name>
          <email>marianna.parlato@inserm.fr</email>
          <xref rid="aff3" ref-type="aff">3</xref>
          <xref rid="cor2" ref-type="corresp">&#x2217;&#x2217;</xref>
        </contrib>
        <aff id="aff1"><label>1</label>Department of Biochemistry and Molecular Biology, CHU d&#x2019;Angers, 49000 Angers, France</aff>
        <aff id="aff2"><label>2</label>University of Angers, MitoVasc, UMR CNRS 6015, INSERM 1083, 49933 Angers, France</aff>
        <aff id="aff3"><label>3</label>Universit&#xE9; de Paris, Imagine Institute, Laboratory of Intestinal Immunity, INSERM, UMR1163, 75015 Paris, France</aff>
        <aff id="aff4"><label>4</label>Sorbonne Universit&#xE9;, INSERM, CNRS, Institut de la Vision, 17 Rue Moreau, 75012 Paris, France</aff>
        <aff id="aff5"><label>5</label>Institut Curie, PSL Research University, INSERM U934, CNRS UMR3215, 75005 Paris, France</aff>
        <aff id="aff6"><label>6</label>Department of Pediatric Gastroenterology, Assistance Publique-H&#xF4;pitaux de Paris, H&#xF4;pital Necker-Enfants Malades, 75015 Paris, France</aff>
        <aff id="aff7"><label>7</label>Department of Molecular Genetics, Assistance Publique-H&#xF4;pitaux de Paris, H&#xF4;pital Necker-Enfants Malades, 75015 Paris, France</aff>
        <aff id="aff8"><label>8</label>Genomics Core Facility, Institut Imagine-Structure F&#xE9;d&#xE9;rative de Recherche Necker, INSERM U1163 et INSERM US24/CNRS UMS3633, Paris Descartes Sorbonne Paris Cit&#xE9; University, 75015 Paris, France</aff>
        <aff id="aff9"><label>9</label>Bioinformatics Core Facility, INSERM-UMR 1163, Imagine Institute, 75015 Paris, France</aff>
        <aff id="aff10"><label>10</label>IRSD, Universit&#xE9; de Toulouse, INSERM, INRA, ENVT, UPS, Toulouse 31300, France</aff>
        <aff id="aff11"><label>11</label>Centre de R&#xE9;f&#xE9;rence des Maladies Rares Digestives, and Pediatric Clinical Research Unit, Toulouse Clinical Investigation Center INSERM U1436, H&#xF4;pital des Enfants, CHU de Toulouse, Toulouse 31300, France</aff>
        <aff id="aff12"><label>12</label>Reference Centre for Marfan Syndrome and Reference Centre on Rare Bone Diseases, Pediatric Clinical Research Unit, Children&#x2019;s Hospital, Toulouse University Hospital, RESTORE, INSERM UMR1301, 31300 Toulouse, France</aff>
        <aff id="aff13"><label>13</label>Centre de G&#xE9;n&#xE9;tique, Centre de R&#xE9;f&#xE9;rence des Maladies Vasculaires Rares, Assistance Publique-H&#xF4;pitaux de Paris, H&#xF4;pital Europ&#xE9;en Georges Pompidou, 75015 Paris, France</aff>
        <aff id="aff14"><label>14</label>Universit&#xE9; de Paris, Imagine Institute, Laboratory of Embryology and Genetics of Malformations, INSERM UMR 1163, 75015 Paris, France</aff>
        <aff id="aff15"><label>15</label>F&#xE9;d&#xE9;ration de G&#xE9;n&#xE9;tique, H&#xF4;pital Necker-Enfants Malades, Assistance Publique H&#xF4;pitaux de Paris, 75015 Paris, France</aff>
        <aff id="aff16"><label>16</label>Centre de R&#xE9;f&#xE9;rence Anomalies du D&#xE9;veloppement et Syndromes Malformatifs, FHU TRANSLAD, H&#xF4;pital d&#x2019;Enfants, CHU Dijon, 21000 Dijon, France</aff>
        <aff id="aff17"><label>17</label>D&#xE9;partement de G&#xE9;n&#xE9;tique M&#xE9;dicale, CHU de Hautepierre, 67200 Strasbourg, France</aff>
        <aff id="aff18"><label>18</label>Nephrology and Transplantation Department, Nouvel H&#xF4;pital Civil, H&#xF4;pitaux Universitaires de Strasbourg, 67200 Strasbourg, France</aff>
        <aff id="aff19"><label>19</label>Medical Genetics Institute, Meir Medical Center, Kfar-Saba 4428164, Israel</aff>
        <aff id="aff20"><label>20</label>Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 6997801, Israel</aff>
        <aff id="aff21"><label>21</label>Genomic Research Department, Emedgene Technologies, 67443 Tel Aviv, Israel</aff>
        <aff id="aff22"><label>22</label>Victorian Clinical Genetics Services, Murdoch Children&#x2019;s Research Institute, Parkville 3052, Melbourne, VIC, Australia</aff>
        <aff id="aff23"><label>23</label>Department of Paediatrics, The University of Melbourne, 3010 Parkville, Melbourne, VIC, Australia</aff>
        <aff id="aff24"><label>24</label>Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany</aff>
        <aff id="aff25"><label>25</label>Department of Medical Genetics, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal 576104, India</aff>
        <aff id="aff26"><label>26</label>Broad Center for Mendelian Genomics, Program in Medical and Population Genetics, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA</aff>
        <aff id="aff27"><label>27</label>Department of Neuromuscular Disorders, Queen Square Institute of Neurology, University College London, WC1N 3BG London, UK</aff>
        <aff id="aff28"><label>28</label>Department of Otolaryngology&#x2013;Head &amp; Neck Surgery, T&#xFC;bingen Hearing Research Centre, Eberhard Karls University of T&#xFC;bingen, 72076 T&#xFC;bingen, Germany</aff>
        <aff id="aff29"><label>29</label>Institute of Human Genetics, Julius Maximilians University W&#xFC;rzburg, 97074 W&#xFC;rzburg, Germany</aff>
        <aff id="aff30"><label>30</label>Molecular and Clinical Sciences Institute, St. George&#x2019;s, University of London, Cranmer Terrace London, SW17 ORE London, UK</aff>
        <aff id="aff31"><label>31</label>Innovative Medical Research Center, Mashhad Branch, Islamic Azdad University, Mashhad 9133736351, Iran</aff>
        <aff id="aff32"><label>32</label>Department of Dermatology, CHU d&#x2019;Angers, 49000 Angers, France</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1"><label>&#x2217;</label>Corresponding author <email>filippo.del-bene@inserm.fr</email></corresp>
        <corresp id="cor2"><label>&#x2217;&#x2217;</label>Corresponding author <email>marianna.parlato@inserm.fr</email></corresp>
        <fn id="fn1">
          <label>33</label>
          <p id="ntpara0010">These authors contributed equally to this work</p>
        </fn>
      </author-notes>
      <pub-date pub-type="pmc-release">
        <day>18</day>
        <month>5</month>
        <year>2021</year>
      </pub-date>
      <!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.-->
      <pub-date pub-type="ppub">
        <day>03</day>
        <month>6</month>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>18</day>
        <month>5</month>
        <year>2021</year>
      </pub-date>
      <volume>108</volume>
      <issue>6</issue>
      <fpage>1126</fpage>
      <lpage>1137</lpage>
      <history>
        <date date-type="received">
          <day>24</day>
          <month>1</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>23</day>
          <month>4</month>
          <year>2021</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2021 The Authors</copyright-statement>
        <copyright-year>2021</copyright-year>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
          <license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p>
        </license>
      </permissions>
      <related-article related-article-type="article-reference" id="d34e12" ext-link-type="doi" xlink:href="10.1016/j.ajhg.2021.04.019"/>
      <abstract id="abs0010">
        <title>Summary</title>
        <p>Dysregulated transforming growth factor TGF-&#x3B2; signaling underlies the pathogenesis of genetic disorders affecting the connective tissue such as Loeys-Dietz syndrome. Here, we report 12 individuals with bi-allelic loss-of-function variants in <italic>IPO8</italic> who presented with a syndromic association characterized by cardio-vascular anomalies, joint hyperlaxity, and various degree of dysmorphic features and developmental delay as well as immune dysregulation; the individuals were from nine unrelated families. Importin 8 belongs to the karyopherin family of nuclear transport receptors and was previously shown to mediate TGF-&#x3B2;-dependent SMADs trafficking to the nucleus <italic>in&#xA0;vitro</italic>. The important <italic>in&#xA0;vivo</italic> role of IPO8 in pSMAD nuclear translocation was demonstrated by CRISPR/Cas9-mediated inactivation in zebrafish. Consistent with IPO8&#x2019;s role in BMP/TGF-&#x3B2; signaling, <italic>ipo8</italic><sup><italic>&#x2212;/&#x2212;</italic></sup> zebrafish presented mild to severe dorso-ventral patterning defects during early embryonic development. Moreover, <italic>ipo8</italic><sup><italic>&#x2212;/&#x2212;</italic></sup> zebrafish displayed severe cardiovascular and skeletal defects that mirrored the human phenotype. Our work thus provides evidence that IPO8 plays a critical and non-redundant role in TGF-&#x3B2; signaling during development and reinforces the existing link between TGF-&#x3B2; signaling and connective tissue defects.</p>
      </abstract>
      <kwd-group id="kwrds0010">
        <title>Keywords</title>
        <kwd>
          <italic>IPO8</italic>
        </kwd>
        <kwd>connective tissue disorder</kwd>
        <kwd>TGF-&#x3B2; signaling</kwd>
        <kwd>Loeys-Dietz syndrome</kwd>
        <kwd>joint hyperlaxity</kwd>
        <kwd>arterial dilatation</kwd>
      </kwd-group>
    </article-meta>
    <notes>
      <p id="misc0010">Published: May 18, 2021</p>
    </notes>
  </front>
  <body>
    <sec id="sec1">
      <title>Main text</title>
      <p id="p0010">First isolated as a RanGTP-binding protein, importin 8 encoded by <italic>IPO8</italic> (MIM: <ext-link ext-link-type="omim" xlink:href="605600" id="intref0010">605600</ext-link>) was then identified as a member of the &#x3B2;-karyopherin family, the largest group of nuclear transport receptors.<xref rid="bib1" ref-type="bibr"><sup>1</sup></xref><sup>,</sup><xref rid="bib2" ref-type="bibr"><sup>2</sup></xref> Accordingly, <italic>in&#xA0;vitro</italic> studies have implicated importin 8 in cytoplasm-to-nucleus shuttling of a broad spectrum of cargos, including the signal recognition particle protein SRP19,<xref rid="bib3" ref-type="bibr"><sup>3</sup></xref> Argonaute-microRNAs complexes,<xref rid="bib4" ref-type="bibr"><sup>4</sup></xref><sup>,</sup><xref rid="bib5" ref-type="bibr"><sup>5</sup></xref> the c-Jun protein,<xref rid="bib6" ref-type="bibr"><sup>6</sup></xref> the NF-&#x3BA;B p65 subunit,<xref rid="bib7" ref-type="bibr"><sup>7</sup></xref> the eukaryotic translation initiation factor eIF4E,<xref rid="bib8" ref-type="bibr"><sup>8</sup></xref> and a set of receptor-activated mothers against decapentaplegic homolog (SMAD) transcription factors<xref rid="bib9" ref-type="bibr"><sup>9</sup></xref> that play a critical role downstream of the large family of tumor growth factor &#x3B2; (TGF-&#x3B2;) and bone morphogenetic protein (BMP) cytokines. In contrast, <italic>in&#xA0;vivo</italic> data on <italic>IPO8</italic> functions are lacking except for a report in <italic>Drosophila</italic> showing that Msk, the ortholog of mammalian importins 7 and 8 (which share 60% homology), mediates nuclear accumulation of phosphorylated MAD downstream of decapentaplegic, the homolog of mammalian BMP.<xref rid="bib10" ref-type="bibr"><sup>10</sup></xref> Msk inactivation was embryonically lethal, suggesting its key role in <italic>Drosophila</italic> development, but no link was clearly established with impairment of BMP signaling.<xref rid="bib10" ref-type="bibr"><sup>10</sup></xref></p>
      <p id="p0015">Strikingly, the TGF-&#x3B2;/BMP cytokine family exerts pleiotropic functions during embryonic development, tissue homeostasis, and tissue repair as well as within the immune system.<xref rid="bib11" ref-type="bibr"><sup>11</sup></xref> Accordingly, dysregulation of TGF-&#x3B2; signaling is the cause of severe congenital disorders characterized by developmental defects with or without impaired immune regulation.<xref rid="bib12" ref-type="bibr"><sup>12</sup></xref> This is notably the case of Loeys-Dietz syndrome (LDS), which is caused by heterozygous loss-of-function (LOF) variants in <italic>TGFBR1</italic> (MIM: <ext-link ext-link-type="omim" xlink:href="190181" id="intref0015">190181</ext-link>), <italic>TGFBR2</italic> (MIM: <ext-link ext-link-type="omim" xlink:href="190182" id="intref0020">190182</ext-link>), <italic>TGFB2</italic> (MIM: <ext-link ext-link-type="omim" xlink:href="190220" id="intref0025">190220</ext-link>) or <italic>TGFB3</italic> (MIM: <ext-link ext-link-type="omim" xlink:href="190230" id="intref0030">190230</ext-link>), and <italic>SMAD2</italic> (MIM: <ext-link ext-link-type="omim" xlink:href="601366" id="intref0035">601366</ext-link>) or <italic>SMAD3</italic> (MIM: <ext-link ext-link-type="omim" xlink:href="603109" id="intref0040">603109</ext-link>);<xref rid="bib13" ref-type="bibr"><sup>13</sup></xref> of Shprintzen-Goldberg syndrome (SGS), which results from heterozygous variants in <italic>SKI</italic> (MIM: <ext-link ext-link-type="omim" xlink:href="182212" id="intref0045">182212</ext-link>), a negative regulator of the TGF-&#x3B2; signaling pathway;<xref rid="bib14" ref-type="bibr"><sup>14</sup></xref> and of Marfan syndrome (MFS) (MIM: <ext-link ext-link-type="omim" xlink:href="154700" id="intref0050">154700</ext-link>) caused by variants in <italic>FBN1</italic> (MIM: <ext-link ext-link-type="omim" xlink:href="134797" id="intref0055">134797</ext-link>), encoding fibrillin-1, the main component of extracellular matrix microfibrils that, in turn, scaffolds latent TGF-&#x3B2;. Thus, individuals with LDS, SGS, and MFS display systemic connective tissue disorders of variable expressivity, which notably affect the vascular tree and the skeleton, causing life-threatening arterial aneurysms, dysmorphic features, pectus deformity, scoliosis, and joint hyperlaxity.<xref rid="bib14" ref-type="bibr"><sup>14</sup></xref><sup>,</sup><xref rid="bib15" ref-type="bibr"><sup>15</sup></xref> In keeping with the immunoregulatory functions of TGF-&#x3B2;,<xref rid="bib16" ref-type="bibr"><sup>16</sup></xref><sup>,</sup><xref rid="bib17" ref-type="bibr"><sup>17</sup></xref> developmental defects of LDS have been associated with increased frequency of allergic manifestations<xref rid="bib18" ref-type="bibr"><sup>18</sup></xref> and a 10-fold increase in the risk of inflammatory bowel diseases (IBDs).<xref rid="bib19" ref-type="bibr"><sup>19</sup></xref> More recently, bi-allelic LOF variants in <italic>TGFB1</italic> (MIM: <ext-link ext-link-type="omim" xlink:href="190180" id="intref0060">190180</ext-link>) were identified as the cause of a severe syndrome combining very early-onset IBD and encephalopathy.<xref rid="bib20" ref-type="bibr"><sup>20</sup></xref></p>
      <p id="p0020">Here, we report 12 individuals with bi-allelic pathogenic <italic>IPO8</italic> variants who displayed a complex syndrome reminiscent of LDS and SGS that variably combined cardiovascular, neurologic, skeletal and immunologic abnormalities along with dysmorphic features; the individuals are from nine unrelated families (<xref rid="tbl1" ref-type="table">Table 1</xref>, <xref rid="fig1" ref-type="fig">Figures 1</xref> and <xref rid="mmc1" ref-type="supplementary-material">S1</xref>). Affected individuals were recruited through an international collaborative effort facilitated by Genematcher.<xref rid="bib21" ref-type="bibr"><sup>21</sup></xref> All procedures were performed in accordance with the Helsinki Declaration and were approved by the ethics committees and the institutional review boards from each center. Sequencing (targeted/whole-exome sequencing and Sanger sequencing) was performed after obtaining informed written consent from all affected individuals or their legal guardians. <xref rid="tbl1" ref-type="table">Table 1</xref> summarizes the main phenotypic features in the cohort. Seven individuals showed early-onset (before the age of 1 year for the youngest) dilatation of the ascending aorta. Individuals 1 and 2 (I-1 and I-2), the two oldest siblings (59 and 53 years old at the time of the first assessment, respectively) had diffuse arterial frailty with multiple aneurysms affecting the abdominal aorta, iliac, coronary, and renal arteries and, in I-1, the thoracic aorta (<xref rid="fig1" ref-type="fig">Figure&#xA0;1</xref>A). Arterial tortuosity similar to that observed in LDS<xref rid="bib22" ref-type="bibr"><sup>22</sup></xref> was noted in four individuals. Recurrent spontaneous pneumothorax was noted in I-1 and I-2. Pulmonary emphysema was present in I-1 (<xref rid="fig1" ref-type="fig">Figure&#xA0;1</xref>B) as well as in two younger individuals (I-5 and I-6). Facial dysmorphism was observed in ten individuals (<xref rid="fig1" ref-type="fig">Figure&#xA0;1</xref>C, <xref rid="tbl1" ref-type="table">Table 1</xref>), while 11 had joint hyperlaxity complicated by multiple joint dislocations. All displayed skeletal features, including scoliosis (n = 9), pectus excavatum or carinatum (n = 6), arachnodactyly (n = 6), or pes planus or talipes equinovarus (n = 6) (<xref rid="fig1" ref-type="fig">Figures 1</xref>D&#x2013;1F and <xref rid="mmc1" ref-type="supplementary-material">S1</xref>). Eight individuals developed myopia complicated by retinal detachment for two of them and by early-onset cataract for two others, but none of them had lens dislocation. In line with a generalized connective tissue disorder, skin hyperextensibility and/or hernia were observed in 11 individuals (<xref rid="fig1" ref-type="fig">Figure&#xA0;1</xref>G). Delayed motor milestone presumably consecutive to joint instability was observed in seven individuals; four of them also had mild (I-5, I-6, and I-8) or severe (I-7) intellectual disability. Predisposition to allergic or inflammatory diseases, which was previously documented in LDS,<xref rid="bib18" ref-type="bibr"><sup>18</sup></xref><sup>,</sup><xref rid="bib19" ref-type="bibr"><sup>19</sup></xref> was evidenced in six individuals (I-5, I-6, I-7, I-8, I-10, and I-12), some of whom also displayed immunological parameters consistent with impaired TGF-&#x3B2; signaling, including hyperIgE, hyperIgG, hypoIgA, and hypereosinophilia.<table-wrap position="float" id="tbl1"><label>Table 1</label><caption><p>Clinical features of individuals carrying <italic>IPO8</italic> variants</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th colspan="2">Family 1</th><th colspan="2">Family 2</th><th colspan="2">Family 3</th><th>Family 4</th><th>Family 5</th><th>Family 6</th><th>Family 7</th><th>Family 8</th><th>Family 9</th><th>Total</th></tr></thead><tbody><tr><td>Individual</td><td>I-1</td><td>I-2</td><td>I-3</td><td>I-4</td><td>I-5</td><td>I-6</td><td>I-7</td><td>I-8</td><td>I-9</td><td>I-10</td><td>I-11</td><td>I-12</td><td>&#x2013;</td></tr><tr><td>Sex</td><td>M</td><td>F</td><td>M</td><td>M</td><td>F</td><td>M</td><td>M</td><td>M</td><td>F</td><td>F</td><td>M</td><td>F</td><td>&#x2013;</td></tr><tr><td>Age at last examination</td><td>62 years</td><td>62 years</td><td>1 year 8&#xA0;months</td><td>2 years 2&#xA0;months</td><td>16 years</td><td>15 years</td><td>9 years 6&#xA0;months</td><td>13 years</td><td>22 years</td><td>33 years</td><td>7 years 6&#xA0;months</td><td>26 years</td><td>&#x2013;</td></tr><tr><td colspan="14"><hr/></td></tr><tr><td colspan="14"><bold>Vascular abnormalities</bold></td></tr><tr><td colspan="14"><hr/></td></tr><tr><td>Dilatation of the ascending aorta</td><td>yes</td><td>yes</td><td>yes</td><td>no</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>11/12</td></tr><tr><td>Other abnormal great vessels</td><td>dilated and calcified iliac arteries, AAA</td><td>calcified coronary arteries, AAA, dilated iliac arteries</td><td>no</td><td>no</td><td>carotid artery tortuosity</td><td>carotid artery tortuosity</td><td>no</td><td>no</td><td>carotid artery tortuosity</td><td>no</td><td>no</td><td>internal carotid tortuosity and ectasia</td><td>6/12</td></tr><tr><td>Heart malformation</td><td>MVP</td><td>no</td><td>ASD, left atrium and ventricle mild dilatation</td><td>no</td><td>ASD, VSD</td><td>no</td><td>N/A</td><td>N/A</td><td>ASD</td><td>ASD, VSD</td><td>MVP</td><td>no</td><td>6/10</td></tr><tr><td colspan="14"><hr/></td></tr><tr><td colspan="14"><bold>Ocular abnormalities</bold></td></tr><tr><td colspan="14"><hr/></td></tr><tr><td>Myopia</td><td>severe</td><td>severe</td><td>no</td><td>no</td><td>severe</td><td>no</td><td>no</td><td>severe</td><td>severe</td><td>mild</td><td>severe</td><td>severe</td><td>8/12</td></tr><tr><td>Retinal detachment</td><td>yes</td><td>yes</td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td><td>2/12</td></tr><tr><td colspan="14"><hr/></td></tr><tr><td colspan="14"><bold>Dysmorphic features</bold></td></tr><tr><td colspan="14"><hr/></td></tr><tr><td>Proptosis</td><td>no</td><td>no</td><td>yes</td><td>no</td><td>no</td><td>yes</td><td>yes</td><td>no</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>7/12</td></tr><tr><td>Micrognathia</td><td>no</td><td>no</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>no</td><td>yes</td><td>no</td><td>no</td><td>yes</td><td>7/12</td></tr><tr><td>Hypertelorism</td><td>no</td><td>no</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>no</td><td>no</td><td>no</td><td>yes</td><td>no</td><td>6/12</td></tr><tr><td>Frontal bossing</td><td>no</td><td>no</td><td>yes</td><td>no</td><td>yes</td><td>yes</td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td><td>3/12</td></tr><tr><td>Ptosis</td><td>no</td><td>no</td><td>yes</td><td>no</td><td>no</td><td>no</td><td>yes</td><td>no</td><td>no</td><td>no</td><td>yes</td><td>no</td><td>3/12</td></tr><tr><td>Abnormal palate</td><td>no</td><td>no</td><td>cleft uvula</td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td><td>no</td><td>cleft uvula</td><td>no</td><td>2/12</td></tr><tr><td colspan="14"><hr/></td></tr><tr><td colspan="14"><bold>Skeletal abnormalities</bold></td></tr><tr><td colspan="14"><hr/></td></tr><tr><td>Hyperlaxity</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>no</td><td>yes</td><td>11/12</td></tr><tr><td>Recurrent joint dislocations</td><td>yes</td><td>yes</td><td>yes</td><td>no</td><td>no</td><td>no</td><td>yes</td><td>no</td><td>yes</td><td>yes</td><td>no</td><td>yes</td><td>7/12</td></tr><tr><td>Pectus</td><td>no</td><td>no</td><td>carinatum</td><td>carinatum</td><td>excavatum</td><td>excavatum</td><td>no</td><td>no</td><td>excavatum</td><td>no</td><td>carinatum</td><td>no</td><td>6/12</td></tr><tr><td>Scoliosis</td><td>yes</td><td>yes</td><td>no</td><td>no</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>no</td><td>9/12</td></tr><tr><td>Arachnodactyly</td><td>no</td><td>no</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>no</td><td>no</td><td>yes</td><td>no</td><td>yes</td><td>no</td><td>6/12</td></tr><tr><td>Feet malposition</td><td>no</td><td>no</td><td>yes</td><td>yes</td><td>no</td><td>no</td><td>no</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>no</td><td>6/12</td></tr><tr><td colspan="14"><hr/></td></tr><tr><td colspan="14"><bold>Connective tissue abnormalities</bold></td></tr><tr><td colspan="14"><hr/></td></tr><tr><td>Skin hyperextensibility</td><td>no</td><td>no</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>no</td><td>yes</td><td>no</td><td>yes</td><td>yes</td><td>yes</td><td>8/12</td></tr><tr><td>Hernia</td><td>umbilical hernia</td><td>spigelian and umbilical hernia</td><td>inguinal, umbilical, diaphragmatic hernia</td><td>umbilical hernia</td><td>umbilical and inguinal hernia</td><td>umbilical and inguinal hernia</td><td>umbilical and inguinal hernia</td><td>umbilical hernia</td><td>no</td><td>umbilical and abdominal hernia</td><td>umbilical hernia</td><td>umbilical and abdominal hernia</td><td>11/12</td></tr><tr><td>Developmental delay/intellectual disability</td><td>no</td><td>no</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>yes</td><td>no</td><td>no</td><td>yes</td><td>no</td><td>7/12</td></tr><tr><td colspan="14"><hr/></td></tr><tr><td colspan="14"><bold>Immunological abnormalities</bold></td></tr><tr><td colspan="14"><hr/></td></tr><tr><td>HyperIgE</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td><td>yes</td><td>yes</td><td>N/A</td><td>yes</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td><td>3/3</td></tr><tr><td>HyperIgG</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td><td>yes</td><td>yes</td><td>N/A</td><td>yes</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td><td>3/3</td></tr><tr><td>HypoIgA</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td><td>yes</td><td>yes</td><td>N/A</td><td>yes</td><td>N/A</td><td>N/A</td><td>no</td><td>N/A</td><td>3/4</td></tr><tr><td>Hypereosinophilia</td><td>mild</td><td>N/A</td><td>N/A</td><td>N/A</td><td>yes</td><td>yes</td><td>N/A</td><td>yes</td><td>N/A</td><td>N/A</td><td>no</td><td>N/A</td><td>4/5</td></tr><tr><td>Intestinal inflammation</td><td>no</td><td>no</td><td>no</td><td>no</td><td>severe colitis</td><td>celiac disease/ gastritis</td><td>no</td><td>dysimmune gastroenterocolitis</td><td>no</td><td>no</td><td>chronic gastritis and duodenitis</td><td>celiac disease</td><td>5/12</td></tr><tr><td>Allergic symptoms</td><td>no</td><td>no</td><td>no</td><td>no</td><td>asthma, eczema</td><td>asthma, eczema</td><td>asthma</td><td>eczema,<break/>rhinoconjunctivitis</td><td>no</td><td>asthma</td><td>no</td><td>drug allergies</td><td>6/12</td></tr><tr><td>Urogenital/kidney anomalies</td><td>large cortical cyst</td><td>ischemic nephropathy</td><td>ureterohydronephrosis</td><td>no</td><td>pyelo-ureteral duplication</td><td>no</td><td>N/A</td><td>ureterohydronephrosis</td><td>no</td><td>no</td><td>hydronephrosis</td><td>no</td><td>6/11</td></tr></tbody></table><table-wrap-foot><fn><p>AAA, ascending aortic aneurysm; ASD, atrial septal defect; MVP, mitral valve prolapse; VSD, ventricular septal defect; N/A, not available. Severe myopia was defined as of &#x2212;6.00 diopters or greater.</p></fn></table-wrap-foot></table-wrap><fig id="fig1"><label>Figure&#xA0;1</label><caption><p>Clinical features of affected individuals</p><p>(A) CT scan showing dilated aortic root and thoracic aorta (TA), calcified asymmetric large femoral arteries (FA), calcified and dilated abdominal aorta (AA), and large renal cyst (white star) in individual 1.</p><p>(B) CT scan showing emphysema of the apex of the left lung in individual 1.</p><p>(C) Proptosis, micrognathia, and hypertelorism in individuals 3, 4, and 10.</p><p>(D) X-ray showing scoliosis in individuals 1 and 7.</p><p>(E) Arachnodactyly in individuals 3 and 7.</p><p>(F) Hyperlaxity of small and large joints in individuals 10 and 7.</p><p>(G) Pes planus and talipes equinovarus in individuals 10 and 3, respectively.</p><p>(H) Skin hyperextensibility in individuals 4, 7, and 10 and umbilical hernia in individual 5.</p></caption><graphic xlink:href="gr1"/></fig></p>
      <p id="p0025">As detailed in <xref rid="tbl2" ref-type="table">Table 2</xref>, 11 variants were identified in the 12 individuals: seven as homozygous and four as compound heterozygous in <italic>IPO8</italic> (GenBank: <ext-link ext-link-type="uri" xlink:href="ncbi-n:NM_006390.3" id="intref0065">NM_006390.3</ext-link>). This gene (25 exons, 24 introns) encodes a 1,037 amino acid protein with the &#x3B2;-importin N-terminal domain (22&#x2013;102 aa) and a CSE1-like domain (202&#x2013;441 aa) containing a RanGTPase-binding motif characteristic of &#x3B2;-importins (<xref rid="fig2" ref-type="fig">Figures 2</xref>A and 2B). Segregation of the variant within each family was analyzed by Sanger sequencing (<xref rid="mmc1" ref-type="supplementary-material">Figure&#xA0;S2</xref>) whenever DNA was available (n = 8). They were all exceedingly rare (MAF &lt; 0.01%), and only three&#xA0;were found in the gnomAD at a heterozygous state (<xref rid="tbl2" ref-type="table">Table 2</xref>).<table-wrap position="float" id="tbl2"><label>Table 2</label><caption><p>Characteristics of <italic>IPO8</italic> variants identified by next-generation sequencing in affected individuals</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Individual</th><th>Chromosome position (Hg19-GRCh37) chr12</th><th>cDNA change (GenBank: <ext-link ext-link-type="uri" xlink:href="ncbi-n:NM_006390.3" id="intref0125">NM_006390.3</ext-link>)</th><th>Amino acid change</th><th>SIFT</th><th>PolyPhen</th><th>DANN</th><th>CADD</th><th>Mutation Taster</th><th>Allele frequency gnomAD</th></tr></thead><tbody><tr><td>1&#x2013;2</td><td>g.30837296C&gt;T</td><td>c.262G&gt;A</td><td>p.Asp88Asn</td><td>damaging</td><td>probably damaging</td><td>0.9989</td><td>25.3</td><td>disease causing</td><td>not observed</td></tr><tr><td>3&#x2013;4</td><td>g.30792531G&gt;A</td><td>c.2407C&gt;T</td><td>p.Arg803<sup>&#x2217;</sup></td><td>N/A</td><td>N/A</td><td>0.9979</td><td>36</td><td>disease causing</td><td>3.98E&#x2212;6, no homozygotes</td></tr><tr><td>5&#x2013;6</td><td>g.30848500G&gt;A</td><td>c.82C&gt;T</td><td>p.Gln28<sup>&#x2217;</sup></td><td>N/A</td><td>N/A</td><td>0.9984</td><td>39</td><td>disease causing</td><td>not observed</td></tr><tr><td>7</td><td>g.30789909_30789913del</td><td>c.2695+3_2695+7delAAAGT</td><td>N/A</td><td>N/A</td><td>N/A</td><td>N/A</td><td>22.8</td><td>disease causing</td><td>not observed</td></tr><tr><td rowspan="2">8</td><td>g.30816479del</td><td>c.1538delC</td><td>p.Pro513Leufs<sup>&#x2217;</sup>13</td><td>N/A</td><td>N/A</td><td>N/A</td><td>33</td><td>disease causing</td><td>not observed</td></tr><tr><td>g.30802094A&gt;G</td><td>c.2245T&gt;C</td><td>p.Cys749Arg</td><td>damaging</td><td>probably damaging</td><td>0.9978</td><td>28.4</td><td>disease causing</td><td>not observed</td></tr><tr><td>9</td><td>g.30790111G&gt;A</td><td>c.2500C&gt;T</td><td>p.Arg834Trp</td><td>damaging</td><td>probably damaging</td><td>0.9993</td><td>32</td><td>disease causing</td><td>4.03E&#x2212;6, no homozygotes</td></tr><tr><td rowspan="2">10</td><td>g.30784946C&gt;T</td><td>c.2900&#x2212;1G&gt;A</td><td>N/A</td><td>N/A</td><td>N/A</td><td>0.9935</td><td>34</td><td>disease causing</td><td>not observed</td></tr><tr><td>g.30792659del</td><td>c.2279delT</td><td>p.Leu760Profs<sup>&#x2217;</sup>10</td><td>N/A</td><td>N/A</td><td>N/A</td><td>33</td><td>disease causing</td><td>1.06E&#x2212;5, no homozygotes</td></tr><tr><td>11</td><td>g. 30829433del</td><td>c.728del</td><td>p.Pro243Leufs<sup>&#x2217;</sup>27</td><td>N/A</td><td>N/A</td><td>N/A</td><td>33</td><td>disease causing</td><td>not observed</td></tr><tr><td>12</td><td>g.30805169G&gt;C</td><td>c.2129C&gt;G</td><td>p.Ser710<sup>&#x2217;</sup></td><td>N/A</td><td>N/A</td><td>0.9962</td><td>38</td><td>disease causing</td><td>not observed</td></tr></tbody></table></table-wrap><fig id="fig2"><label>Figure&#xA0;2</label><caption><p>Molecular features of identified variants</p><p>(A) Pedigrees of families 1&#x2013;9.</p><p>(B) Schematic representation of <italic>IPO8</italic> gene (25 exons, 24 introns) and importin 8 protein (1,037 amino acids), which features the importin N-terminal domain and the CSE1-like domain, containing tandem HEAT repeats and a RanGTP-binding motif. <italic>IPO8</italic> variants identified in this study as well as their location are shown. Protein sequence alignments of IPO8 orthologs are provided for each affected residue.</p><p>(C) Importin 8 expression in fibroblasts or EBV cells derived from individuals 2, 5, 6, 8, and 9. GAPDH served as loading control.</p></caption><graphic xlink:href="gr2"/></fig></p>
      <p id="p0030">Out of the seven homozygous variants, four were likely LOF variants (three nonsense, c.2407C&gt;T [p.Arg803<sup>&#x2217;</sup>], c.82C&gt;T [p.Gln28<sup>&#x2217;</sup>], and c.2129C&gt;G [p.Ser710<sup>&#x2217;</sup>], and one frameshift c.728delC [p.Pro243Leufs<sup>&#x2217;</sup>27]), one was a splicing variant (c.2695+3_2695+7delAAAGT), and two were missense (c.262G&gt;A [p.Asp88Asn] and c.2500C&gt;T [p.Arg834Trp]). The compound heterozygous variants were frameshift variants leading to a premature stop codon (c.2279delT [p.Leu760ProfsTer10] and c.1538delC [p.Pro513Leufs<sup>&#x2217;</sup>13]) in <italic>trans</italic> with a splicing (c.2900&#x2212;1G&gt;A) and a missense variant (c.2245T&gt;C [p.Cys749Arg]), respectively. Both, c.2695+3_2695+7delAAAGT and c.2900&#x2212;1G&gt;A variants were predicted to impact the splicing according to SpliceAI.<xref rid="bib23" ref-type="bibr"><sup>23</sup></xref> Although the lack of available biospecimens or DNA from I-10 (family 7) prevented assessment of the splicing variant C.2900&#x2212;1 G&gt;A, analysis of the c.2695+3_2695+7delAAAGT variant by minigene assay demonstrated that it resulted in exon 22 skipping and activation of a cryptic splicing site (<xref rid="mmc1" ref-type="supplementary-material">Figure&#xA0;S3</xref>). The <italic>IPO8</italic> missense variants, namely p.Asp88Asn, p.Cys749Arg, and p.Arg834Trp, affected highly conserved residues among IPO8 orthologs and were predicted to be damaging by several <italic>in silico</italic> tools, including CADD score (<xref rid="fig2" ref-type="fig">Figure&#xA0;2</xref>B).</p>
      <p id="p0035">The impact of variants on protein level was evaluated by immunoblot analysis of protein lysates from primary cells, either fibroblasts or Epstein-Barr virus-immortalized B cell lines (EBV-B cells). A striking reduction of IPO8 level was observed in the four individuals who could be tested, including I-2 and I-9, who carried homozygous missense variants (<xref rid="fig2" ref-type="fig">Figure&#xA0;2</xref>C). The overlap of clinical features between all the affected individuals and the rarity or absence of the identified <italic>IPO8</italic> variants in population databases, including LOF variants and three missense variants impairing protein level and/or with predicted damaging effect on protein function, strongly supported IPO8 deficiency as disease causing in all the 12 individuals.</p>
      <p id="p0040">We next assessed how <italic>ipo8</italic> disruption might affect development by using a zebrafish model and focused attention on early dorso-ventral patterning defects that are a telltale sign of altered TGF-&#x3B2;/BMP signaling, as well as on skeletal and cardiovascular defects that were the main clinical hallmarks in the cohort. The zebrafish genome encodes one single <italic>ipo8</italic> ortholog with 72% identity and 85% similarity with human IPO8. IPO8 mutants were generated via CRISPR/Cas9 genome editing and two RNA guides simultaneously. The selected fish line carried both one insertion and two deletions (indels) in exon 4 that overall resulted in alternative translation from amino acid 125 and introduction of an early stop codon after amino acid 136 (<xref rid="fig3" ref-type="fig">Figure&#xA0;3</xref>A). Zygotic mutants derived from the incross of two heterozygous parents (<italic>ipo8</italic><sup>idv1</sup><sup><italic>/+</italic></sup> or simply <italic>ipo8</italic><sup><italic>+/&#x2212;</italic></sup>) did not develop any obvious phenotype and could be grown to adulthood, a result in keeping with the fact that maternal factors stored as mRNAs and proteins in the egg can compensate for zygotic loss of function during embryonic stages of zebrafish.<xref rid="bib24" ref-type="bibr"><sup>24</sup></xref><sup>,</sup><xref rid="bib25" ref-type="bibr"><sup>25</sup></xref> In order to obtain maternal-zygotic mutants (MZ <italic>ipo8</italic><sup>&#x2212;/&#x2212;</sup>, here referred to simply as <italic>ipo8</italic><sup>&#x2212;/&#x2212;</sup>) that lacked wild-type (WT) ipo8 provided in the egg by the mother, we incrossed homozygous <italic>ipo8</italic> zygotic mutant adults. Their homozygous WT siblings were incrossed as controls. At 10&#xA0;h post fertilization (hpf) (bud stage), <italic>ipo8</italic><sup>&#x2212;/&#x2212;</sup> MZ embryos appeared ovoid rather than round (<xref rid="fig3" ref-type="fig">Figure&#xA0;3</xref>B). Moreover, during the following early somite stages, their tail bud failed to extend around the yolk but extended off prematurely, generating elongated, pear-shaped embryos (86% of 36 embryos from 3 clutches). These early morphological changes correlated with increased death rate that varied between 20% to 100% of the embryos per clutch. As development proceeded, a range of tail elongation defects became apparent, from embryos displaying an entirely normal or only partially absent ventral tail fin to embryos with a strongly twisted body axis resembling a snail shell-like trunk (<xref rid="fig3" ref-type="fig">Figure&#xA0;3</xref>C). In addition, at 3&#xA0;days post fertilization (dpf), most embryos (81% of 83 larvae from 6 clutches) developed heart edemas (as highlighted by arrows in <xref rid="fig3" ref-type="fig">Figure&#xA0;3</xref>C). Morphological changes were strongly pronounced in the tail region, while anterior parts appeared comparatively normal with well-developed eyes and visible midbrain-hindbrain boundaries. These features are typical of dorsalized zebrafish mutants that result from mutations affecting the specification of ventral regions.<xref rid="bib26" ref-type="bibr"><sup>26</sup></xref> To quantify the dorsalization phenotypic spectrum of the <italic>ipo8</italic><sup>&#x2212;/&#x2212;</sup> mutants, we evaluated each analyzed clutch at 24 hpf and divided the phenotypes into five severity classes as previously described.<xref rid="bib26" ref-type="bibr"><sup>26</sup></xref> A normal phenotype was observed in 96.5% of WT embryos but only 4.5% of <italic>ipo8</italic><sup>&#x2212;/&#x2212;</sup> embryos, which displayed a whole spectrum of dorsalization phenotypes (<xref rid="fig3" ref-type="fig">Figures 3</xref>D and 3E).<fig id="fig3"><label>Figure&#xA0;3</label><caption><p>Zebrafish <italic>ipo8</italic> mutants show a range of dorsalization phenotypes</p><p>(A) Schematics of CRISPR/Cas9-mediated gene disruption at the <italic>ipo8</italic> genomic locus. The sgRNAs (sg5 and sg6, blue arrows) targeted exon 4. Compared to the wild-type (WT) sequence, the mutated allele from the founder fish (<italic>mut</italic>) displayed two deletions of 18 and 22 bases and an insertion of 34&#xA0;bp generating a frameshift from amino acid 124 and a premature STOP codon after 136 amino acids.</p><p>(B) Bright field pictures of bud (10 hpf) and early somite stages (12 hpf) embryos showing the elongating shape of the <italic>ipo8</italic><sup><italic>&#x2212;/&#x2212;</italic></sup> embryos compared to WT controls. Scale bar represents 500&#xA0;&#x3BC;m.</p><p>(C) Bright field pictures of 3 dpf larvae presenting the variable penetrance of the <italic>ipo8</italic><sup><italic>&#x2212;/&#x2212;</italic></sup> phenotype (mild and strong) compared to WT controls. The tail fin is circled with dashed lines when visible. Gaps are highlighted by arrowheads. Arrows point at heart edema. Scale bar represents 200&#xA0;&#x3BC;m.</p><p>(D) Nomarski pictures depicting the different classes of the dorsalization phenotype at 24 hpf as described in Mullins et&#xA0;al.<xref rid="bib26" ref-type="bibr"><sup>26</sup></xref> (from severe C5 to mild C1) in the <italic>ipo8</italic><sup><italic>&#x2212;/&#x2212;</italic></sup> mutants compared to the normal phenotype of a WT embryo. Scale bar represents 200&#xA0;&#x3BC;m.</p><p>(E) Quantification of the distribution of the dorsalization classes in <italic>ipo8</italic><sup><italic>&#x2212;/&#x2212;</italic></sup> mutants (5 clutches, n = 903) compared to WT clutches (4 WT clutches, n = 503). Average values in <italic>ipo8</italic><sup><italic>&#x2212;/&#x2212;</italic></sup> mutants were 7.3% C5, 34.6% C4, 28.0% C3, 16.0% C2, 9.6% C1, and 4.5% normal, and average values in WT controls were 0% C5, 0.8% C4, 1.6% C3, 1.1% C2, 0% C1, and 96.5% normal.</p></caption><graphic xlink:href="gr3"/></fig></p>
      <p id="p0045">To dissect these morphological defects at the molecular level, we performed whole-mount <italic>in situ</italic> hybridization analysis to reveal mRNA expression of early patterning genes in embryos (<xref rid="mmc1" ref-type="supplementary-material">Figure&#xA0;S4</xref>). <italic>Ntl</italic> showed a shorter and broader expression pattern indicating defects in axial mesoderm elongation (<xref rid="mmc1" ref-type="supplementary-material">Figure&#xA0;S4</xref>A). <italic>Gata1</italic> showed reduced expression limited to the posterior side, indicating ventral mesoderm specification defects (<xref rid="mmc1" ref-type="supplementary-material">Figure&#xA0;S4</xref>B). In addition, the paraxial mesoderm marker <italic>myoD</italic> showed a shorter and broader pattern, underlying defects in convergent-extension gastrulation movements (<xref rid="mmc1" ref-type="supplementary-material">Figure&#xA0;S4</xref>C). Overall, these defects in <italic>ipo8</italic> mutants appeared comparable to those reported in zebrafish dorsalized mutants, which affect members of BMP and TGF-&#x3B2; signaling (e.g., <italic>bmp2</italic>, <italic>bmp7</italic>, <italic>alk8</italic>, and <italic>smad5</italic>).<xref rid="bib27" ref-type="bibr"><sup>27</sup></xref><sup>,</sup><xref rid="bib28" ref-type="bibr"><sup>28</sup></xref> To investigate skeletal defects in the <italic>ipo8</italic><sup>&#x2212;/&#x2212;</sup> zebrafish model, we analyzed expression of the transcription factor sox9a, a marker of chondrogenic precursor development (<xref rid="mmc1" ref-type="supplementary-material">Figure&#xA0;S4</xref>D). Shorter trabeculae of the neurocranium were observed in mutant embryos by 2 dpf. In the tail region, <italic>sox9a</italic> expression was strongly reduced or appeared in irregular patches along the spinal cord axis, consistent with defects in vertebrae formation. Heart and vessel morphologies were analyzed after crossing the <italic>ipo8</italic> mutant line with a transgenic line expressing a reporter fluorescently labeling blood vessels in living embryos (<italic>Tg</italic>(<italic>kdrl:Hsa.HRAS-mCherry</italic>)). Analysis at 2 dpf revealed severe defects in heart chamber formation and atrial and ventricular chambers were less or not delimited in <italic>ipo8</italic><sup>&#x2212;/&#x2212;</sup> mutants (<xref rid="fig4" ref-type="fig">Figure&#xA0;4</xref>A). <italic>Ipo8</italic><sup>&#x2212;/&#x2212;</sup> mutants also exhibited arterio-venous malformations in the head and over 70% of mutant embryos in 5 independent clutches showed abnormal arterio-venous connections in the dorsal midline junction and poorly differentiated central arteries that appeared irregular, thin, and poorly lumenized (<xref rid="fig4" ref-type="fig">Figure&#xA0;4</xref>B). By 3 dpf, various severe cardiovascular defects were observed in mutant embryos, including heart edema and, in the subset of embryos with mild tail morphological defects (normal or C1 class in <xref rid="fig3" ref-type="fig">Figure&#xA0;3</xref>D), various blood vessel patterning abnormalities that resulted in the absence of blood circulation or abnormal blood flow in the tail region (e.g., looping or clogging, <xref rid="fig4" ref-type="fig">Figure&#xA0;4</xref>C).<fig id="fig4"><label>Figure&#xA0;4</label><caption><p><italic>Ipo8</italic> deficiency causes cardiovascular defects in zebrafish</p><p>(A) Defects in heart chamber formation exemplified by two maximal projections of confocal <italic>Z</italic> stacks of the hearts of WT and <italic>ipo8</italic><sup><italic>&#x2212;/&#x2212;</italic></sup> 48 hpf embryos carrying the kdrl:mCherry transgene to label endothelial cells. For each line, the third panel shows the overlays of the outlines of the 7 (WT) and 11 <italic>(ipo8</italic><sup><italic>&#x2212;/&#x2212;</italic></sup><italic>)</italic> analyzed hearts. a, atrium; v, ventricle. Scale bar represents 30&#xA0;&#x3BC;m.</p><p>(B) Maximal projections of depth color-coded confocal <italic>Z</italic> stacks of the head vessels of WT and <italic>ipo8</italic><sup><italic>&#x2212;/&#x2212;</italic></sup> embryos at 48 hpf, and quantifications of the percentage of fish showing dorsal midline junction (DMJ) defects and central arteries (CA) differentiation defects. Twenty-three WT and 30 <italic>ipo8</italic><sup><italic>&#x2212;/&#x2212;</italic></sup> embryos from 3 and 5 clutches, respectively, were analyzed. Median and IQR are shown. p values were calculated by Mann Whitney test (<sup>&#x2217;</sup>p &lt; 0.05). +, abnormal DMJ; arrowheads, abnormal CA. Scale bar represents 100&#xA0;&#x3BC;m.</p><p>(C) Maximal projections of time-lapses of Nomarsky imaging of the tails of 3 dpf larvae highlighting absence of blood circulation (no flow) or defects in blood vessel patterning (abnormal path and clogging) in <italic>ipo8</italic><sup><italic>&#x2212;/&#x2212;</italic></sup> mutants. Arrows indicate flow direction. Scale bar represents 200&#xA0;&#x3BC;m.</p></caption><graphic xlink:href="gr4"/></fig></p>
      <p id="p0050">Putative defects in TGF-&#x3B2;/BMP signaling in the <italic>ipo8</italic><sup>&#x2212;/&#x2212;</sup> mutants were next investigated with an antibody specific for pSmad1/5/9. This antibody revealed the expected ventral to dorsal gradient of pSmad1/5/9 detected in WT gastrulating embryos with nuclear localization in the ventral part. In <italic>ipo8</italic><sup>&#x2212;/&#x2212;</sup> embryos, nuclear localization of pSmad was significantly reduced (<xref rid="fig5" ref-type="fig">Figures 5</xref>A and 5B). In contrast and in keeping with a defect in pSMAD translocation in <italic>ipo8</italic><sup>&#x2212;/&#x2212;</sup> embryos, the pSMAD signal was detected in the cytoplasm and at membranes, as shown by its colocalization with phalloidin at cell outlines.<fig id="fig5"><label>Figure&#xA0;5</label><caption><p>pSMAD nuclear translocation defects in <italic>ipo8</italic><sup><italic>&#x2212;/&#x2212;</italic></sup> embryos highlight impaired TGF-&#x3B2;/BMP signaling</p><p>(A) Maximal projections of confocal <italic>Z</italic> stacks of WT and <italic>ipo8</italic><sup><italic>&#x2212;/&#x2212;</italic></sup> embryos labeled for pSmad1/5/9 (green) and DAPI (blue) showing well-defined ventral to dorsal gradient of pSmad5 in WT gastrulating zebrafish embryos (left panel) but not in the <italic>ipo8</italic><sup><italic>&#x2212;/&#x2212;</italic></sup> embryos (right panel). Scale bar represents 100&#xA0;&#x3BC;m.</p><p>(B) Confocal images of the ventral sides of WT and <italic>ipo8</italic><sup><italic>&#x2212;/&#x2212;</italic></sup> embryos labeled for pSmad1/5/9 (green), phalloidin (red), and DAPI (blue). Arrowheads highlight the membrane localization of the pSmad staining in the <italic>ipo8</italic><sup><italic>&#x2212;/&#x2212;</italic></sup> mutants. Scale bar represents 20&#xA0;&#x3BC;m. Dot plots representative of three experiments show quantifications of the ratio of pSmad1/5/9 cytoplasmic signal over nuclear signal; 5 WT and 6 <italic>ipo8</italic><sup><italic>&#x2212;/&#x2212;</italic></sup> embryos were analyzed. Median and IQR are shown. p values were calculated by Mann Whitney test (<sup>&#x2217;&#x2217;</sup>p &lt; 0.01).</p><p>(C) Heatmaps of differentially expressed genes between WT and <italic>ipo8</italic><sup><italic>&#x2212;/&#x2212;</italic></sup> embryos at 13 and 24 hpf. Three to four biological replicates are shown per group. The top enriched gene ontology term for biological process is highlighted for each cluster.</p></caption><graphic xlink:href="gr5"/></fig></p>
      <p id="p0055">To further demonstrate the role of <italic>ipo8</italic> in TGF-&#x3B2;/BMP signaling during development, we compared the transcriptomes of WT and <italic>ipo8</italic><sup>&#x2212;/&#x2212;</sup> embryos at two different time points during early embryogenesis (13 and 24 hpf) (<xref rid="fig5" ref-type="fig">Figure&#xA0;5</xref>C). We chose these early developmental stages to avoid secondary effects deriving from abnormalities developing later on. <italic>Ipo8</italic> itself, as expected, was significantly downregulated in <italic>ipo8</italic><sup><italic>&#x2212;/&#x2212;</italic></sup> fish (<xref rid="mmc1" ref-type="supplementary-material">Figure&#xA0;S5</xref>A). Principal-component analysis (PCA) showed close clustering of biological replicates and a clear segregation of the <italic>ipo8</italic><sup><italic>&#x2212;/&#x2212;</italic></sup> samples from WT samples both at 13 and 24 hpf (<xref rid="mmc1" ref-type="supplementary-material">Figure&#xA0;S5</xref>B). Genes differentially regulated between the <italic>ipo8</italic><sup>&#x2212;/&#x2212;</sup> and WT embryos (adjusted p value &lt; 0.01) were analyzed by pathway enrichment analysis (<xref rid="fig5" ref-type="fig">Figure&#xA0;5</xref>C). Strikingly, genes differentially regulated upon ipo8 depletion encoded multiple components of the TGF-&#x3B2;/BMP pathway as well as genes involved in angiotensin/angiogenesis pathways. Notably, expression of <italic>smad7</italic>, one of the direct transcriptional targets of the TGF-&#x3B2;/BMP pathway, was strongly decreased in <italic>ipo8</italic><sup>&#x2212;/&#x2212;</sup> embryos compared to WT at both 13 and 24 hpf, compatible with lack of translocation to the nucleus and, as a consequence, impaired downstream activation of SMAD-dependent transcription.</p>
      <p id="p0060">Overall, our zebrafish model demonstrates that importin 8 plays a critical role during the early stage of development by controlling pSmad nuclear translocation and downstream TGF-&#x3B2;/BMP-dependent transcription. Because homozygous <italic>ipo8</italic><sup><italic>&#x2212;/&#x2212;</italic></sup> embryos born from heterozygous parents were normal, and because the abnormal phenotype was observed only in MZ mutant embryos, it is likely that Ipo8 is not essential after the initial embryogenesis occurs. This may be due to genetic compensation<xref rid="bib29" ref-type="bibr"><sup>29</sup></xref> or simply to Ipo8 function&#x2019;s being redundant with that of a paralog. We cannot, however, exclude subtler cellular/organ phenotypes that may occur later in development or in adult animals and have not been characterized in this study. Importantly, data in the zebrafish model support a causative role of IPO8 deficiency in the vascular and skeleton defects observed in all affected individuals. While our results indicate a role for Ipo8 via the nuclear translocation of phosphorylated SMAD proteins, future investigation remains necessary to define whether and how the role of IPO8 in the translocation of other putative cargoes<xref rid="bib3" ref-type="bibr">3</xref>, <xref rid="bib4" ref-type="bibr">4</xref>, <xref rid="bib5" ref-type="bibr">5</xref>, <xref rid="bib6" ref-type="bibr">6</xref>, <xref rid="bib7" ref-type="bibr">7</xref> (see above) may participate in the phenotypic features of IPO8 deficiency.</p>
      <p id="p0065">In summary, we have identified <italic>IPO8</italic> deficiency as the cause of a previously uncharacterized syndrome that is inherited in an autosomal-recessive pattern. This syndrome is characterized by deregulation of TGF-&#x3B2; signaling pathway and overlaps clinically with other TGF-&#x3B2; signalopathies: MFS, LDS, and SGS as depicted in <xref rid="mmc1" ref-type="supplementary-material">Figure&#xA0;S6</xref> and <xref rid="mmc1" ref-type="supplementary-material">Table S1</xref>. Common features observed in IPO8 individuals and shared with LDS, MFS, and SGS include cardiovascular anomalies with notably strong predisposition for ascending aorta aneurysm and facial and skeletal anomalies (<xref rid="mmc1" ref-type="supplementary-material">Table S1</xref>). Other less recurrent manifestations displayed by IPO8-deficient individuals were immune dysregulation and allergic diseases, which have also been reported in a subset of LDS-affected individuals,<xref rid="bib30" ref-type="bibr"><sup>30</sup></xref> and developmental delay that was observed in SGS.<xref rid="bib14" ref-type="bibr"><sup>14</sup></xref> The accompanying article by Van Gucht et&#xA0;al.<xref rid="bib31" ref-type="bibr"><sup>31</sup></xref> in this issue of <italic>The American Journal of Human Genetics</italic> reports largely overlapping developmental abnormalities in seven additional <italic>IPO8</italic>-deficient individuals.<xref rid="bib31" ref-type="bibr"><sup>31</sup></xref> Their data showing that the loss of ipo8 causes severe early-onset thoracic aortic aneurysm in a mouse model supports the causative role of the gene defect in the most severe manifestation of the disease and complements our demonstration that IPO8 plays a crucial role in TGF-&#x3B2;-dependent organogenesis and in cardio-vascular development in the zebrafish model. Overall, the identification of IPO8 deficiency as cause of TGF-&#x3B2; signalopathy stresses the essential functions of this pathway in development, patterning, and homeostasis of the affected tissues.</p>
    </sec>
    <sec sec-type="COI-statement" id="app5">
      <title>Declaration of interests</title>
      <p id="p0135">The authors declare no competing interests.</p>
    </sec>
  </body>
  <back>
    <ref-list id="cebib0010">
      <title>References</title>
      <ref id="bib1">
        <label>1</label>
        <element-citation publication-type="journal" id="sref1">
          <person-group person-group-type="author">
            <name>
              <surname>G&#xF6;rlich</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Dabrowski</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Bischoff</surname>
              <given-names>F.R.</given-names>
            </name>
            <name>
              <surname>Kutay</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Bork</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Hartmann</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Prehn</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Izaurralde</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>A novel class of RanGTP binding proteins</article-title>
          <source>J.&#xA0;Cell Biol.</source>
          <volume>138</volume>
          <year>1997</year>
          <fpage>65</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="pmid">9214382</pub-id>
        </element-citation>
      </ref>
      <ref id="bib2">
        <label>2</label>
        <element-citation publication-type="journal" id="sref2">
          <person-group person-group-type="author">
            <name>
              <surname>Stewart</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>Molecular mechanism of the nuclear protein import cycle</article-title>
          <source>Nat. Rev. Mol. Cell Biol.</source>
          <volume>8</volume>
          <year>2007</year>
          <fpage>195</fpage>
          <lpage>208</lpage>
          <pub-id pub-id-type="pmid">17287812</pub-id>
        </element-citation>
      </ref>
      <ref id="bib3">
        <label>3</label>
        <element-citation publication-type="journal" id="sref3">
          <person-group person-group-type="author">
            <name>
              <surname>Dean</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>von Ahsen</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>G&#xF6;rlich</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Fried</surname>
              <given-names>H.M.</given-names>
            </name>
          </person-group>
          <article-title>Signal recognition particle protein 19 is imported into the nucleus by importin 8 (RanBP8) and transportin</article-title>
          <source>J.&#xA0;Cell Sci.</source>
          <volume>114</volume>
          <year>2001</year>
          <fpage>3479</fpage>
          <lpage>3485</lpage>
          <pub-id pub-id-type="pmid">11682607</pub-id>
        </element-citation>
      </ref>
      <ref id="bib4">
        <label>4</label>
        <element-citation publication-type="journal" id="sref4">
          <person-group person-group-type="author">
            <name>
              <surname>Wei</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>C.-Y.</given-names>
            </name>
            <name>
              <surname>Zen</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Importin 8 regulates the transport of mature microRNAs into the cell nucleus</article-title>
          <source>J.&#xA0;Biol. Chem.</source>
          <volume>289</volume>
          <year>2014</year>
          <fpage>10270</fpage>
          <lpage>10275</lpage>
          <pub-id pub-id-type="pmid">24596094</pub-id>
        </element-citation>
      </ref>
      <ref id="bib5">
        <label>5</label>
        <element-citation publication-type="journal" id="sref5">
          <person-group person-group-type="author">
            <name>
              <surname>Weinmann</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>H&#xF6;ck</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Ivacevic</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Ohrt</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>M&#xFC;tze</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Schwille</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Kremmer</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Benes</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Urlaub</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Meister</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Importin 8 is a gene silencing factor that targets argonaute proteins to distinct mRNAs</article-title>
          <source>Cell</source>
          <volume>136</volume>
          <year>2009</year>
          <fpage>496</fpage>
          <lpage>507</lpage>
          <pub-id pub-id-type="pmid">19167051</pub-id>
        </element-citation>
      </ref>
      <ref id="bib6">
        <label>6</label>
        <element-citation publication-type="journal" id="sref6">
          <person-group person-group-type="author">
            <name>
              <surname>Schreck</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Al-Rawi</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Mingot</surname>
              <given-names>J.-M.</given-names>
            </name>
            <name>
              <surname>Scholl</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Diefenbacher</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>O&#x2019;Donnell</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Bohmann</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Weiss</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>c-Jun localizes to the nucleus independent of its phosphorylation by and interaction with JNK and vice versa promotes nuclear accumulation of JNK</article-title>
          <source>Biochem. Biophys. Res. Commun.</source>
          <volume>407</volume>
          <year>2011</year>
          <fpage>735</fpage>
          <lpage>740</lpage>
          <pub-id pub-id-type="pmid">21439937</pub-id>
        </element-citation>
      </ref>
      <ref id="bib7">
        <label>7</label>
        <element-citation publication-type="journal" id="sref7">
          <person-group person-group-type="author">
            <name>
              <surname>Liang</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Cong</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Luo</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>KPNB1, XPO7 and IPO8 mediate the translocation ofNF-&#x3BA;B/p65 into the nucleus</article-title>
          <source>Traffic</source>
          <volume>14</volume>
          <year>2013</year>
          <fpage>1132</fpage>
          <lpage>1143</lpage>
          <pub-id pub-id-type="pmid">23906023</pub-id>
        </element-citation>
      </ref>
      <ref id="bib8">
        <label>8</label>
        <element-citation publication-type="journal" id="sref8">
          <person-group person-group-type="author">
            <name>
              <surname>Volpon</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Culjkovic-Kraljacic</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Osborne</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Ramteke</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Sun</surname>
              <given-names>Q.</given-names>
            </name>
            <name>
              <surname>Niesman</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Chook</surname>
              <given-names>Y.M.</given-names>
            </name>
            <name>
              <surname>Borden</surname>
              <given-names>K.L.B.</given-names>
            </name>
          </person-group>
          <article-title>Importin 8 mediates m7G cap-sensitive nuclear import of the eukaryotic translation initiation factor eIF4E</article-title>
          <source>Proc. Natl. Acad. Sci. USA</source>
          <volume>113</volume>
          <year>2016</year>
          <fpage>5263</fpage>
          <lpage>5268</lpage>
          <pub-id pub-id-type="pmid">27114554</pub-id>
        </element-citation>
      </ref>
      <ref id="bib9">
        <label>9</label>
        <element-citation publication-type="journal" id="sref9">
          <person-group person-group-type="author">
            <name>
              <surname>Yao</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Cottonham</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>L.</given-names>
            </name>
          </person-group>
          <article-title>Preferential utilization of Imp7/8 in nuclear import of Smads</article-title>
          <source>J.&#xA0;Biol. Chem.</source>
          <volume>283</volume>
          <year>2008</year>
          <fpage>22867</fpage>
          <lpage>22874</lpage>
          <pub-id pub-id-type="pmid">18519565</pub-id>
        </element-citation>
      </ref>
      <ref id="bib10">
        <label>10</label>
        <element-citation publication-type="journal" id="sref10">
          <person-group person-group-type="author">
            <name>
              <surname>Xu</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Yao</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Lu</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Ip</surname>
              <given-names>Y.T.</given-names>
            </name>
          </person-group>
          <article-title>Msk is required for nuclear import of TGF-&#x3B2;/BMP-activated Smads</article-title>
          <source>J.&#xA0;Cell Biol.</source>
          <volume>178</volume>
          <year>2007</year>
          <fpage>981</fpage>
          <lpage>994</lpage>
          <pub-id pub-id-type="pmid">17785517</pub-id>
        </element-citation>
      </ref>
      <ref id="bib11">
        <label>11</label>
        <element-citation publication-type="journal" id="sref11">
          <person-group person-group-type="author">
            <name>
              <surname>David</surname>
              <given-names>C.J.</given-names>
            </name>
            <name>
              <surname>Massagu&#xE9;</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Contextual determinants of TGF&#x3B2; action in development, immunity and cancer</article-title>
          <source>Nat. Rev. Mol. Cell Biol.</source>
          <volume>19</volume>
          <year>2018</year>
          <fpage>419</fpage>
          <lpage>435</lpage>
          <pub-id pub-id-type="pmid">29643418</pub-id>
        </element-citation>
      </ref>
      <ref id="bib12">
        <label>12</label>
        <element-citation publication-type="journal" id="sref12">
          <person-group person-group-type="author">
            <name>
              <surname>MacFarlane</surname>
              <given-names>E.G.</given-names>
            </name>
            <name>
              <surname>Haupt</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Dietz</surname>
              <given-names>H.C.</given-names>
            </name>
            <name>
              <surname>Shore</surname>
              <given-names>E.M.</given-names>
            </name>
          </person-group>
          <article-title>TGF-&#x3B2; Family Signaling in Connective Tissue and Skeletal Diseases</article-title>
          <source>Cold Spring Harb. Perspect. Biol.</source>
          <volume>9</volume>
          <year>2017</year>
          <fpage>a022269</fpage>
          <pub-id pub-id-type="pmid">28246187</pub-id>
        </element-citation>
      </ref>
      <ref id="bib13">
        <label>13</label>
        <element-citation publication-type="journal" id="sref13">
          <person-group person-group-type="author">
            <name>
              <surname>Schepers</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Tortora</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Morisaki</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>MacCarrick</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Lindsay</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Liang</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Mehta</surname>
              <given-names>S.G.</given-names>
            </name>
            <name>
              <surname>Hague</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Verhagen</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>van de Laar</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
          <article-title>A mutation update on the LDS-associated genes TGFB2/3 and SMAD2/3</article-title>
          <source>Hum. Mutat.</source>
          <volume>39</volume>
          <year>2018</year>
          <fpage>621</fpage>
          <lpage>634</lpage>
          <pub-id pub-id-type="pmid">29392890</pub-id>
        </element-citation>
      </ref>
      <ref id="bib14">
        <label>14</label>
        <element-citation publication-type="journal" id="sref14">
          <person-group person-group-type="author">
            <name>
              <surname>Doyle</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Doyle</surname>
              <given-names>J.J.</given-names>
            </name>
            <name>
              <surname>Bessling</surname>
              <given-names>S.L.</given-names>
            </name>
            <name>
              <surname>Maragh</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Lindsay</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Schepers</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Gillis</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Mortier</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Homfray</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Sauls</surname>
              <given-names>K.</given-names>
            </name>
          </person-group>
          <article-title>Mutations in the TGF-&#x3B2; repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm</article-title>
          <source>Nat. Genet.</source>
          <volume>44</volume>
          <year>2012</year>
          <fpage>1249</fpage>
          <lpage>1254</lpage>
          <pub-id pub-id-type="pmid">23023332</pub-id>
        </element-citation>
      </ref>
      <ref id="bib15">
        <label>15</label>
        <element-citation publication-type="journal" id="sref15">
          <person-group person-group-type="author">
            <name>
              <surname>Loeys</surname>
              <given-names>B.L.</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Neptune</surname>
              <given-names>E.R.</given-names>
            </name>
            <name>
              <surname>Judge</surname>
              <given-names>D.P.</given-names>
            </name>
            <name>
              <surname>Podowski</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Holm</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Meyers</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Leitch</surname>
              <given-names>C.C.</given-names>
            </name>
            <name>
              <surname>Katsanis</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Sharifi</surname>
              <given-names>N.</given-names>
            </name>
          </person-group>
          <article-title>A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2</article-title>
          <source>Nat. Genet.</source>
          <volume>37</volume>
          <year>2005</year>
          <fpage>275</fpage>
          <lpage>281</lpage>
          <pub-id pub-id-type="pmid">15731757</pub-id>
        </element-citation>
      </ref>
      <ref id="bib16">
        <label>16</label>
        <element-citation publication-type="journal" id="sref16">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Ten Dijke</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Immunoregulation by members of the TGF&#x3B2; superfamily</article-title>
          <source>Nat. Rev. Immunol.</source>
          <volume>16</volume>
          <year>2016</year>
          <fpage>723</fpage>
          <lpage>740</lpage>
          <pub-id pub-id-type="pmid">27885276</pub-id>
        </element-citation>
      </ref>
      <ref id="bib17">
        <label>17</label>
        <element-citation publication-type="journal" id="sref17">
          <person-group person-group-type="author">
            <name>
              <surname>Kelly</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Houston</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Sherwood</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Casulli</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Travis</surname>
              <given-names>M.A.</given-names>
            </name>
          </person-group>
          <article-title>Regulation of Innate and Adaptive Immunity by TGF&#x3B2;</article-title>
          <source>Adv. Immunol.</source>
          <volume>134</volume>
          <year>2017</year>
          <fpage>137</fpage>
          <lpage>233</lpage>
          <pub-id pub-id-type="pmid">28413021</pub-id>
        </element-citation>
      </ref>
      <ref id="bib18">
        <label>18</label>
        <element-citation publication-type="journal" id="sref18">
          <person-group person-group-type="author">
            <name>
              <surname>Frischmeyer-Guerrerio</surname>
              <given-names>P.A.</given-names>
            </name>
            <name>
              <surname>Guerrerio</surname>
              <given-names>A.L.</given-names>
            </name>
            <name>
              <surname>Oswald</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Chichester</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Myers</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Halushka</surname>
              <given-names>M.K.</given-names>
            </name>
            <name>
              <surname>Oliva-Hemker</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Wood</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Dietz</surname>
              <given-names>H.C.</given-names>
            </name>
          </person-group>
          <article-title>TGF&#x3B2; receptor mutations impose a strong predisposition for human allergic disease</article-title>
          <source>Sci. Transl. Med.</source>
          <volume>5</volume>
          <year>2013</year>
          <fpage>195ra94</fpage>
        </element-citation>
      </ref>
      <ref id="bib19">
        <label>19</label>
        <element-citation publication-type="journal" id="sref19">
          <person-group person-group-type="author">
            <name>
              <surname>Guerrerio</surname>
              <given-names>A.L.</given-names>
            </name>
            <name>
              <surname>Frischmeyer-Guerrerio</surname>
              <given-names>P.A.</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Wu</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Haritunians</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>McGovern</surname>
              <given-names>D.P.B.</given-names>
            </name>
            <name>
              <surname>MacCarrick</surname>
              <given-names>G.L.</given-names>
            </name>
            <name>
              <surname>Brant</surname>
              <given-names>S.R.</given-names>
            </name>
            <name>
              <surname>Dietz</surname>
              <given-names>H.C.</given-names>
            </name>
          </person-group>
          <article-title>Increased Prevalence of Inflammatory Bowel Disease in Patients with Mutations in Genes Encoding the Receptor Subunits for TGF&#x3B2;</article-title>
          <source>Inflamm. Bowel Dis.</source>
          <volume>22</volume>
          <year>2016</year>
          <fpage>2058</fpage>
          <lpage>2062</lpage>
          <pub-id pub-id-type="pmid">27508510</pub-id>
        </element-citation>
      </ref>
      <ref id="bib20">
        <label>20</label>
        <element-citation publication-type="journal" id="sref20">
          <person-group person-group-type="author">
            <name>
              <surname>Kotlarz</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Marquardt</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Bar&#xF8;y</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>W.S.</given-names>
            </name>
            <name>
              <surname>Konnikova</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Hollizeck</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Magg</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Lehle</surname>
              <given-names>A.S.</given-names>
            </name>
            <name>
              <surname>Walz</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Borggraefe</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
          <article-title>Human TGF-&#x3B2;1 deficiency causes severe inflammatory bowel disease and encephalopathy</article-title>
          <source>Nat. Genet.</source>
          <volume>50</volume>
          <year>2018</year>
          <fpage>344</fpage>
          <lpage>348</lpage>
          <pub-id pub-id-type="pmid">29483653</pub-id>
        </element-citation>
      </ref>
      <ref id="bib21">
        <label>21</label>
        <element-citation publication-type="journal" id="sref21">
          <person-group person-group-type="author">
            <name>
              <surname>Sobreira</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Schiettecatte</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Valle</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Hamosh</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>GeneMatcher: a matching tool for connecting investigators with an interest in the same gene</article-title>
          <source>Hum. Mutat.</source>
          <volume>36</volume>
          <year>2015</year>
          <fpage>928</fpage>
          <lpage>930</lpage>
          <pub-id pub-id-type="pmid">26220891</pub-id>
        </element-citation>
      </ref>
      <ref id="bib22">
        <label>22</label>
        <element-citation publication-type="journal" id="sref22">
          <person-group person-group-type="author">
            <name>
              <surname>Loeys</surname>
              <given-names>B.L.</given-names>
            </name>
            <name>
              <surname>Schwarze</surname>
              <given-names>U.</given-names>
            </name>
            <name>
              <surname>Holm</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Callewaert</surname>
              <given-names>B.L.</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>G.H.</given-names>
            </name>
            <name>
              <surname>Pannu</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>De Backer</surname>
              <given-names>J.F.</given-names>
            </name>
            <name>
              <surname>Oswald</surname>
              <given-names>G.L.</given-names>
            </name>
            <name>
              <surname>Symoens</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Manouvrier</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Aneurysm syndromes caused by mutations in the TGF-beta receptor</article-title>
          <source>N.&#xA0;Engl. J. Med.</source>
          <volume>355</volume>
          <year>2006</year>
          <fpage>788</fpage>
          <lpage>798</lpage>
          <pub-id pub-id-type="pmid">16928994</pub-id>
        </element-citation>
      </ref>
      <ref id="bib23">
        <label>23</label>
        <element-citation publication-type="journal" id="sref23">
          <person-group person-group-type="author">
            <name>
              <surname>Jaganathan</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Kyriazopoulou Panagiotopoulou</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>McRae</surname>
              <given-names>J.F.</given-names>
            </name>
            <name>
              <surname>Darbandi</surname>
              <given-names>S.F.</given-names>
            </name>
            <name>
              <surname>Knowles</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Y.I.</given-names>
            </name>
            <name>
              <surname>Kosmicki</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Arbelaez</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Cui</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>G.B.</given-names>
            </name>
          </person-group>
          <article-title>Predicting Splicing from Primary Sequence with Deep Learning</article-title>
          <source>Cell</source>
          <volume>176</volume>
          <year>2019</year>
          <fpage>535</fpage>
          <lpage>548.e24</lpage>
          <pub-id pub-id-type="pmid">30661751</pub-id>
        </element-citation>
      </ref>
      <ref id="bib24">
        <label>24</label>
        <element-citation publication-type="journal" id="sref24">
          <person-group person-group-type="author">
            <name>
              <surname>Abrams</surname>
              <given-names>E.W.</given-names>
            </name>
            <name>
              <surname>Mullins</surname>
              <given-names>M.C.</given-names>
            </name>
          </person-group>
          <article-title>Early zebrafish development: it&#x2019;s in the maternal genes</article-title>
          <source>Curr. Opin. Genet. Dev.</source>
          <volume>19</volume>
          <year>2009</year>
          <fpage>396</fpage>
          <lpage>403</lpage>
          <pub-id pub-id-type="pmid">19608405</pub-id>
        </element-citation>
      </ref>
      <ref id="bib25">
        <label>25</label>
        <element-citation publication-type="journal" id="sref25">
          <person-group person-group-type="author">
            <name>
              <surname>Stainier</surname>
              <given-names>D.Y.R.</given-names>
            </name>
            <name>
              <surname>Raz</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Lawson</surname>
              <given-names>N.D.</given-names>
            </name>
            <name>
              <surname>Ekker</surname>
              <given-names>S.C.</given-names>
            </name>
            <name>
              <surname>Burdine</surname>
              <given-names>R.D.</given-names>
            </name>
            <name>
              <surname>Eisen</surname>
              <given-names>J.S.</given-names>
            </name>
            <name>
              <surname>Ingham</surname>
              <given-names>P.W.</given-names>
            </name>
            <name>
              <surname>Schulte-Merker</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Yelon</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Weinstein</surname>
              <given-names>B.M.</given-names>
            </name>
          </person-group>
          <article-title>Guidelines for morpholino use in zebrafish</article-title>
          <source>PLoS Genet.</source>
          <volume>13</volume>
          <year>2017</year>
          <fpage>e1007000</fpage>
          <pub-id pub-id-type="pmid">29049395</pub-id>
        </element-citation>
      </ref>
      <ref id="bib26">
        <label>26</label>
        <element-citation publication-type="journal" id="sref26">
          <person-group person-group-type="author">
            <name>
              <surname>Mullins</surname>
              <given-names>M.C.</given-names>
            </name>
            <name>
              <surname>Hammerschmidt</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kane</surname>
              <given-names>D.A.</given-names>
            </name>
            <name>
              <surname>Odenthal</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Brand</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>van Eeden</surname>
              <given-names>F.J.</given-names>
            </name>
            <name>
              <surname>Furutani-Seiki</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Granato</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Haffter</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Heisenberg</surname>
              <given-names>C.P.</given-names>
            </name>
          </person-group>
          <article-title>Genes establishing dorsoventral pattern formation in the zebrafish embryo: the ventral specifying genes</article-title>
          <source>Development</source>
          <volume>123</volume>
          <year>1996</year>
          <fpage>81</fpage>
          <lpage>93</lpage>
          <pub-id pub-id-type="pmid">9007231</pub-id>
        </element-citation>
      </ref>
      <ref id="bib27">
        <label>27</label>
        <element-citation publication-type="journal" id="sref27">
          <person-group person-group-type="author">
            <name>
              <surname>Tucker</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Mintzer</surname>
              <given-names>K.A.</given-names>
            </name>
            <name>
              <surname>Mullins</surname>
              <given-names>M.C.</given-names>
            </name>
          </person-group>
          <article-title>The BMP signaling gradient patterns dorsoventral tissues in a temporally progressive manner along the anteroposterior axis</article-title>
          <source>Dev. Cell</source>
          <volume>14</volume>
          <year>2008</year>
          <fpage>108</fpage>
          <lpage>119</lpage>
          <pub-id pub-id-type="pmid">18194657</pub-id>
        </element-citation>
      </ref>
      <ref id="bib28">
        <label>28</label>
        <element-citation publication-type="journal" id="sref28">
          <person-group person-group-type="author">
            <name>
              <surname>Hammerschmidt</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Mullins</surname>
              <given-names>M.C.</given-names>
            </name>
          </person-group>
          <article-title>Dorsoventral patterning in the zebrafish: bone morphogenetic proteins and beyond</article-title>
          <source>Results Probl. Cell Differ.</source>
          <volume>40</volume>
          <year>2002</year>
          <fpage>72</fpage>
          <lpage>95</lpage>
          <pub-id pub-id-type="pmid">12353487</pub-id>
        </element-citation>
      </ref>
      <ref id="bib29">
        <label>29</label>
        <element-citation publication-type="journal" id="sref29">
          <person-group person-group-type="author">
            <name>
              <surname>Rossi</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Kontarakis</surname>
              <given-names>Z.</given-names>
            </name>
            <name>
              <surname>Gerri</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Nolte</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>H&#xF6;lper</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Kr&#xFC;ger</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Stainier</surname>
              <given-names>D.Y.R.</given-names>
            </name>
          </person-group>
          <article-title>Genetic compensation induced by deleterious mutations but not gene knockdowns</article-title>
          <source>Nature</source>
          <volume>524</volume>
          <year>2015</year>
          <fpage>230</fpage>
          <lpage>233</lpage>
          <pub-id pub-id-type="pmid">26168398</pub-id>
        </element-citation>
      </ref>
      <ref id="bib30">
        <label>30</label>
        <element-citation publication-type="journal" id="sref30">
          <person-group person-group-type="author">
            <name>
              <surname>Cannaerts</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>van de Beek</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Verstraeten</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Van Laer</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Loeys</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>TGF-&#x3B2; signalopathies as a paradigm for translational medicine</article-title>
          <source>Eur. J. Med. Genet.</source>
          <volume>58</volume>
          <year>2015</year>
          <fpage>695</fpage>
          <lpage>703</lpage>
          <pub-id pub-id-type="pmid">26598797</pub-id>
        </element-citation>
      </ref>
      <ref id="bib31">
        <label>31</label>
        <element-citation publication-type="journal" id="sref31">
          <person-group person-group-type="author">
            <name>
              <surname>Van Gucht</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Meester</surname>
              <given-names>J.A.N.</given-names>
            </name>
            <name>
              <surname>Bento</surname>
              <given-names>J.R.</given-names>
            </name>
            <name>
              <surname>Bastiaansen</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Bastianen</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Luyckx</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Van Den Heuvel</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Neutel</surname>
              <given-names>C.H.G.</given-names>
            </name>
            <name>
              <surname>Guns</surname>
              <given-names>P.J.</given-names>
            </name>
            <name>
              <surname>Vermont</surname>
              <given-names>M.</given-names>
            </name>
          </person-group>
          <article-title>A human importin-&#x3B2;-related disorder: Syndromic thoracic aortic aneurysm caused by bi-allelic loss-of-function variants in IPO8</article-title>
          <source>Am. J. Hum. Genet.</source>
          <year>2021</year>
          <pub-id pub-id-type="doi">10.1016/j.ajhg.2021.04.019</pub-id>
          <comment>Published online May 18, 2021</comment>
        </element-citation>
      </ref>
    </ref-list>
    <sec id="app1">
      <title>Data and code availability</title>
      <p id="p0075">The <italic>IPO8</italic> variants were submitted to ClinVar (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/clinvar/" id="intref0070">https://www.ncbi.nlm.nih.gov/clinvar/</ext-link>) (GenBank: <ext-link ext-link-type="uri" xlink:href="ncbi-n:NM_006390.3" id="intref0075">NM_006390.3</ext-link>; accession numbers SCV001571677, SCV001571678, SCV001571679, SCV001571680, SCV001571681, SCV001571682, SCV001571683, SCV001571684, SCV001571685, SCV001571686, and SCV001571687). The WES datasets supporting this study have not been deposited in a public repository because of ethical restriction but are available from the corresponding author on request.</p>
    </sec>
    <sec id="app4">
      <title>Web resources</title>
      <p id="p0090">
        <list list-type="simple" id="ulist0010">
          <list-item id="u0010">
            <p id="p0095">CADD, <ext-link ext-link-type="uri" xlink:href="https://cadd.gs.washington.edu/" id="intref0085">https://cadd.gs.washington.edu/</ext-link></p>
          </list-item>
          <list-item id="u0015">
            <p id="p0100">GenBank, <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/genbank/" id="intref0090">https://www.ncbi.nlm.nih.gov/genbank/</ext-link></p>
          </list-item>
          <list-item id="u0020">
            <p id="p0105">GeneMatcher, <ext-link ext-link-type="uri" xlink:href="https://genematcher.org/" id="intref0095">https://genematcher.org/</ext-link></p>
          </list-item>
          <list-item id="u0025">
            <p id="p0110">gnomAD, <ext-link ext-link-type="uri" xlink:href="https://gnomad.broadinstitute.org/" id="intref0100">https://gnomad.broadinstitute.org/</ext-link></p>
          </list-item>
          <list-item id="u0030">
            <p id="p0115">Mutation Taster, <ext-link ext-link-type="uri" xlink:href="http://www.mutationtaster.org/" id="intref0105">http://www.mutationtaster.org/</ext-link></p>
          </list-item>
          <list-item id="u0035">
            <p id="p0120">OMIM, <ext-link ext-link-type="uri" xlink:href="https://omim.org" id="intref0110">https://omim.org</ext-link></p>
          </list-item>
          <list-item id="u0040">
            <p id="p0125">PolyPhen2, <ext-link ext-link-type="uri" xlink:href="http://genetics.bwh.harvard.edu/pph2/" id="intref0115">http://genetics.bwh.harvard.edu/pph2/</ext-link></p>
          </list-item>
          <list-item id="u0045">
            <p id="p0130">SIFT, <ext-link ext-link-type="uri" xlink:href="https://sift.bii.a-star.edu.sg/" id="intref0120">https://sift.bii.a-star.edu.sg/</ext-link></p>
          </list-item>
        </list>
      </p>
    </sec>
    <sec id="app3" sec-type="supplementary-material">
      <title>Supplemental information</title>
      <p id="p0085">
        <supplementary-material content-type="local-data" id="mmc1">
          <caption>
            <title>Document S1. Supplemental notes, Figures S1&#x2013;S6, Table S1, and supplemental methods</title>
          </caption>
          <media xlink:href="mmc1.pdf"/>
        </supplementary-material>
        <supplementary-material content-type="local-data" id="mmc2">
          <caption>
            <title>Document S2. Article plus supplemental information</title>
          </caption>
          <media xlink:href="mmc2.pdf"/>
        </supplementary-material>
      </p>
    </sec>
    <ack id="ack0010">
      <title>Acknowledgments</title>
      <p id="p0070">We are grateful to the families who participated in this work. We thank Nicole Van Bergen, MCRI, for performing the confirmatory Sanger sequencing in individual 10. This work was supported by <funding-source id="gs1">the Agence Nationale de la Recherche</funding-source> under &#x201C;Investissements d&#x2019;avenir&#x201D; program (ANR-10-IAHU-01), institutional grants from <funding-source id="gs2"><institution-wrap><institution-id institution-id-type="doi">10.13039/501100001677</institution-id><institution>INSERM</institution></institution-wrap></funding-source>, the European grant ERC-2013-AdG-339407-IMMUNOBIOTA, and grants from <funding-source id="gs3">Fondation Princesse Grace</funding-source> and &#x201C;Fondation Maladies Rares&#x201D; (to N.C.B.); by institutional grants from <funding-source id="gs4">the CNRS</funding-source> and <funding-source id="gs5">the University of Angers</funding-source> (to D.B.); by intramural funding (<italic>f</italic>ort&#xFC;ne) at <funding-source id="gs6">the University of T&#xFC;bingen</funding-source> (2545-1-0) and <funding-source id="gs7">the Ministry of Science, Research and Art Baden-W&#xFC;rttemberg</funding-source> (to B.V.); and by <funding-source id="gs8">the Programme Investissements d&#x2019;Avenir IHU FOReSIGHT</funding-source> (ANR-18-IAHU-01) (to F.D.B.). C.R. was supported by an <funding-source id="gs9">EU Horizon 2020</funding-source> Marie Sk&#x142;odowska-Curie Action fellowship (H2020-MSCA-IF-2014 #661527). K.M.G. and K.K. are jointly funded by <funding-source id="gs10">the Indian Council of Medical Research</funding-source> (file no. 5/7/1508/2016 to K.M.G.) and <funding-source id="gs11">the Federal Ministry of Education and Research</funding-source> (01DQ17003 to K.K.). Sequencing and analysis for individual 10 were provided by the Broad Institute of MIT and Harvard Center for Mendelian Genomics (Broad CMG) and was funded by <funding-source id="gs12">the National Human Genome Research Institute</funding-source>, <funding-source id="gs13">the National Eye Institute</funding-source>, and <funding-source id="gs14">the National Heart, Lung, and Blood Institute</funding-source> grant UM1 HG008900 and in part by National Human Genome Research Institute grant R01 HG009141. Funding for the UDP-Vic was provided by philanthropic donation and <funding-source id="gs15">the Murdoch Children&#x2019;s Research Institute</funding-source>. The research conducted at the Murdoch Children&#x2019;s Research Institute was supported by <funding-source id="gs16">the Victorian Government&#x2019;s Operational Infrastructure Support Program</funding-source>, <funding-source id="gs17">the Harbig Family Foundation</funding-source>, and <funding-source id="gs18"><institution-wrap><institution-id institution-id-type="doi">10.13039/100014607</institution-id><institution>The Royal Children's Hospital Foundation</institution></institution-wrap></funding-source>.</p>
    </ack>
    <fn-group>
      <fn id="app2" fn-type="supplementary-material">
        <p id="p0080">Supplemental information can be found online at <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ajhg.2021.04.020" id="intref0080">https://doi.org/10.1016/j.ajhg.2021.04.020</ext-link>.</p>
      </fn>
    </fn-group>
  </back>
</article>
</pmc-articleset>